A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to ...

Wall Street's main indexes were mixed in choppy trading on Friday as investors avoided large bets after data showed consumer ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

But not enough patients visited VillageMD’s doctors, and the business is now up for sale. Brewer exited in September 2023 and Walgreens last year took a $5.8bn after-tax charge related to VillageMD, ...

Deutsche Bank downgraded Walgreens Boots Alliance (WBA) to Sell from Hold with a price target of $9, down from $11. The firm says the reports ...

What the telehealth prescribers can’t do, the compounders are. A major drug compounder association, the Outsourcing Facilities Association, along with member North American Custom Laboratories, LLC, ...

The private-equity suitor is planning on splitting up Walgreens' U.S. and U.K. pharmacy businesses, as well as its specialty ...

Sycamore Partners is eyeing a major Walgreens buyout--splitting the pharmacy giant into three. Will this rescue or wreck the ...

Sycamore Partners is planning a three-way split of Walgreens Boots Alliance if a deal to take the struggling pharmacy chain ...